Miguel Maximiano Morais Moreira
Miguel Maximiano Morais Moreira has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Felipe Matheus Sant’aNna Aragão
Heart Institute of the Hospital das Clínicas, Faculty of Medicine, University of São Paulo (INCOR), São Paulo 05403-900, SP, Brazil
5 shared publications - Iapunira Catarina Sant’aNna Aragão
Postgraduate student in Endocrinology at the Pontifical Catholic University of Rio de Janeiro (MED PUCRio), affiliated with the Luiz Capriglione State Institute of Diabetes and Endocrinology (IEDE), and Emergency Physician at the Munir Rafful Municipal Hospital (MHMR), Rio de Janeiro, Rio de Janeiro, Brazil, Rio de Janeiro, Brazil, Brazil
5 shared publications - José Aderval Aragão
Titular Professor of Clinical Anatomy, Department of Morphology, Federal University of Sergipe (UFS), Aracaju, Sergipe, Brazil
5 shared publications - Francisco Prado Reis
Medical School, Tiradentes University (UNIT), Aracaju 49032-490, SE, Brazil
4 shared publications - Vera Lúcia Correa Feitosa
Department of Medicine and Dentistry, Federal University of Sergipe (UFS), Aracaju 49100-000, Sergipe, Brazil
4 shared publications - Bárbara Costa Lourenço
Faculdade de Ciências Médicas de Três Rios, Brasil
3 shared publications
Latest Publications
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (02)
INTERVENÇÕES TRANSCATETER EM VALVOPATIAS: IMPACTO NOS DESFECHOS CLÍNICOS E REMODELAMENTO CARDÍACO – REVISÃO SISTEMÁTICA E METANÁLISE
Objective: To evaluate the effects of transcatheter interventions on clinical outcomes, safety, and cardiac remodeling in patients with aortic, mitral, and tricuspid valve diseases. Methods: A systematic review including 45 publications corresponding to 21 independent populations was conducted. Randomized clinical trials and prospective studies assessing transcatheter aortic valve implantation or replacement, mitral transcatheter edge-to-edge repair, tricuspid transcatheter edge-to-edge repair, and transcatheter tricuspid valve replacement were included. Meta-analyses were performed only when studies were clinically and methodologically comparable regarding population, intervention, comparator, outcome, and follow-up period. Random-effects models were applied. Risk of bias was assessed using the RoB 2 tool, and the certainty of evidence was evaluated according to the GRADE approach. Results: In aortic valve disease, the meta-analysis of PARTNER 2A, SURTAVI, and PARTNER 3 showed no difference between TAVI/TAVR and surgical aortic valve replacement for all-cause death or disabling stroke at five years (HR=0.98; 95%CI 0.83–1.17; I²=57.4%). The transcatheter approach was associated with lower rates of bleeding, acute kidney injury, and atrial fibrillation, but with higher risks of vascular complications, permanent pacemaker implantation, and residual aortic regurgitation. In secondary mitral regurgitation, the exploratory synthesis of MITRA-FR, COAPT, and RESHAPE-HF2 favored M-TEER, although the result was not statistically significant and heterogeneity was high (HR=0.72; 95%CI 0.49–1.06; I²=72.6%). In tricuspid interventions, the most consistent benefits were observed in quality of life and functional status, without a statistically robust reduction in mortality or heart failure hospitalization at one year. Cardiac remodeling findings suggested favorable hemodynamic and structural changes, but meta-analysis was not feasible because of heterogeneity in parameters and measurement methods. Conclusion: Transcatheter interventions showed clinical efficacy comparable to surgery in aortic valve disease and relevant functional benefits in mitral and tricuspid valve diseases. Individualized patient selection remains essential, particularly in secondary mitral regurgitation and tricuspid regurgitation. Longer follow-up and standardized outcomes are required to clarify durability, cardiac remodeling, and the impact on mortality and hospitalization. Keywords: heart valve diseases; transcatheter aortic valve replacement; mitral valve insufficiency; tricuspid valve insufficiency.
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (02)
INTERVENÇÕES TRANSCATETER EM VALVOPATIAS: IMPACTO NOS DESFECHOS CLÍNICOS E REMODELAMENTO CARDÍACO – REVISÃO SISTEMÁTICA E METANÁLISE
Objective: To evaluate the effects of transcatheter interventions on clinical outcomes, safety, and cardiac remodeling in patients with aortic, mitral, and tricuspid valve diseases. Methods: A systematic review including 45 publications corresponding to 21 independent populations was conducted. Randomized clinical trials and prospective studies assessing transcatheter aortic valve implantation or replacement, mitral transcatheter edge-to-edge repair, tricuspid transcatheter edge-to-edge repair, and transcatheter tricuspid valve replacement were included. Meta-analyses were performed only when studies were clinically and methodologically comparable regarding population, intervention, comparator, outcome, and follow-up period. Random-effects models were applied. Risk of bias was assessed using the RoB 2 tool, and the certainty of evidence was evaluated according to the GRADE approach. Results: In aortic valve disease, the meta-analysis of PARTNER 2A, SURTAVI, and PARTNER 3 showed no difference between TAVI/TAVR and surgical aortic valve replacement for all-cause death or disabling stroke at five years (HR=0.98; 95%CI 0.83–1.17; I²=57.4%). The transcatheter approach was associated with lower rates of bleeding, acute kidney injury, and atrial fibrillation, but with higher risks of vascular complications, permanent pacemaker implantation, and residual aortic regurgitation. In secondary mitral regurgitation, the exploratory synthesis of MITRA-FR, COAPT, and RESHAPE-HF2 favored M-TEER, although the result was not statistically significant and heterogeneity was high (HR=0.72; 95%CI 0.49–1.06; I²=72.6%). In tricuspid interventions, the most consistent benefits were observed in quality of life and functional status, without a statistically robust reduction in mortality or heart failure hospitalization at one year. Cardiac remodeling findings suggested favorable hemodynamic and structural changes, but meta-analysis was not feasible because of heterogeneity in parameters and measurement methods. Conclusion: Transcatheter interventions showed clinical efficacy comparable to surgery in aortic valve disease and relevant functional benefits in mitral and tricuspid valve diseases. Individualized patient selection remains essential, particularly in secondary mitral regurgitation and tricuspid regurgitation. Longer follow-up and standardized outcomes are required to clarify durability, cardiac remodeling, and the impact on mortality and hospitalization. Keywords: heart valve diseases; transcatheter aortic valve replacement; mitral valve insufficiency; tricuspid valve insufficiency.
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (01)
REMODELAMENTO VENTRICULAR E DESFECHOS CLÍNICOS APÓS TERAPIAS TRANSCATETER EM DOENÇAS VALVARES: REVISÃO SISTEMÁTICA E METANÁLISE
Valvular heart diseases are an important cause of cardiovascular morbidity and mortality, especially among older populations and patients with multiple comorbidities. In recent decades, transcatheter therapies have profoundly changed the treatment of aortic stenosis, mitral regurgitation, and tricuspid regurgitation, expanding therapeutic options for patients at high surgical risk or with contraindications to conventional surgery. This systematic review with subgroup-structured meta-analysis aimed to evaluate the effects of transcatheter therapies for valvular heart diseases on left and right ventricular remodeling, as well as their association with clinical outcomes. Thirty studies involving TAVI/TAVR, mitral transcatheter edge-to-edge repair, transcatheter mitral valve replacement, and transcatheter tricuspid interventions were included. Due to the clinical and methodological heterogeneity among the valvular diseases, devices, and populations evaluated, the results were organized by therapeutic subgroups and analyzed through a tabular quantitative synthesis. The findings indicated that TAVI/TAVR presented the most consolidated evidence, being associated with reduced pressure overload, left ventricular reverse remodeling, and improved clinical outcomes across different risk profiles. In mitral therapies, the benefit was more dependent on patient selection, baseline ventricular remodeling, and the proportionality of mitral regurgitation. In tricuspid interventions, improvements in quality of life, reduction of regurgitation, and potential right-sided chamber remodeling were observed, although the effects on mortality still require further confirmation. In conclusion, ventricular remodeling is a relevant marker of therapeutic response and prognosis after transcatheter valve therapies and should be incorporated into clinical, echocardiographic, and methodological assessment in future studies. Keywords: heart valve diseases; transcatheter procedures; ventricular remodeling; meta-analysis.
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (01)
REMODELAMENTO VENTRICULAR E DESFECHOS CLÍNICOS APÓS TERAPIAS TRANSCATETER EM DOENÇAS VALVARES: REVISÃO SISTEMÁTICA E METANÁLISE
Valvular heart diseases are an important cause of cardiovascular morbidity and mortality, especially among older populations and patients with multiple comorbidities. In recent decades, transcatheter therapies have profoundly changed the treatment of aortic stenosis, mitral regurgitation, and tricuspid regurgitation, expanding therapeutic options for patients at high surgical risk or with contraindications to conventional surgery. This systematic review with subgroup-structured meta-analysis aimed to evaluate the effects of transcatheter therapies for valvular heart diseases on left and right ventricular remodeling, as well as their association with clinical outcomes. Thirty studies involving TAVI/TAVR, mitral transcatheter edge-to-edge repair, transcatheter mitral valve replacement, and transcatheter tricuspid interventions were included. Due to the clinical and methodological heterogeneity among the valvular diseases, devices, and populations evaluated, the results were organized by therapeutic subgroups and analyzed through a tabular quantitative synthesis. The findings indicated that TAVI/TAVR presented the most consolidated evidence, being associated with reduced pressure overload, left ventricular reverse remodeling, and improved clinical outcomes across different risk profiles. In mitral therapies, the benefit was more dependent on patient selection, baseline ventricular remodeling, and the proportionality of mitral regurgitation. In tricuspid interventions, improvements in quality of life, reduction of regurgitation, and potential right-sided chamber remodeling were observed, although the effects on mortality still require further confirmation. In conclusion, ventricular remodeling is a relevant marker of therapeutic response and prognosis after transcatheter valve therapies and should be incorporated into clinical, echocardiographic, and methodological assessment in future studies. Keywords: heart valve diseases; transcatheter procedures; ventricular remodeling; meta-analysis.
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (01)
ENDOCRINOLOGIA DE PRECISÃO E RESISTÊNCIA À INSULINA – AVANÇOS EM BIOMARCADORES E TERAPIAS PERSONALIZADAS: REVISÃO SISTEMÁTICA COM ABORDAGEM DE METANÁLISE
Insulin resistance is a central pathophysiological axis of type 2 diabetes mellitus, obesity, metabolic syndrome, and several cardiometabolic conditions. With the advancement of precision endocrinology, this condition has increasingly been understood as a heterogeneous phenotype influenced by clinical, molecular, metabolomic, and therapeutic factors. This study aimed to systematically analyze advances in biomarkers and personalized therapies applied to insulin resistance, using a subgroup meta-analysis approach. A systematic literature review was conducted in recognized scientific databases, including studies on precision medicine, metabolic subclassification, classical biomarkers, metabolomic and molecular biomarkers, and personalized therapeutic interventions. Thirty-three studies were included and organized into four main domains: precision medicine and phenotypic subclassification; classical biomarkers, such as HOMA-IR, QUICKI, Matsuda index, and TyG index; emerging biomarkers, including branched-chain amino acids, α-hydroxybutyrate, metabolomic signatures, and microRNAs; and personalized therapies, such as intensive weight-loss interventions, metabolic surgery, GLP-1 receptor agonists, dual GIP/GLP-1 receptor agonists, and SGLT2 inhibitors. The findings showed that a subgroup-based approach is methodologically more appropriate given the heterogeneity of studies, populations, biomarkers, and interventions. Classical biomarkers remain useful for screening and initial stratification, whereas omics-based markers show potential for prognostic refinement and early identification of metabolic risk. Therapeutic interventions showed greater relevance when targeted to the patient’s clinical and metabolic profile. In conclusion, precision endocrinology applied to insulin resistance represents a promising frontier for early diagnosis, therapeutic personalization, prevention of type 2 diabetes, and reduction of cardiometabolic complications. Keywords: insulin resistance; precision endocrinology; biomarkers; personalized therapies.
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (01)
ENDOCRINOLOGIA DE PRECISÃO E RESISTÊNCIA À INSULINA – AVANÇOS EM BIOMARCADORES E TERAPIAS PERSONALIZADAS: REVISÃO SISTEMÁTICA COM ABORDAGEM DE METANÁLISE
Insulin resistance is a central pathophysiological axis of type 2 diabetes mellitus, obesity, metabolic syndrome, and several cardiometabolic conditions. With the advancement of precision endocrinology, this condition has increasingly been understood as a heterogeneous phenotype influenced by clinical, molecular, metabolomic, and therapeutic factors. This study aimed to systematically analyze advances in biomarkers and personalized therapies applied to insulin resistance, using a subgroup meta-analysis approach. A systematic literature review was conducted in recognized scientific databases, including studies on precision medicine, metabolic subclassification, classical biomarkers, metabolomic and molecular biomarkers, and personalized therapeutic interventions. Thirty-three studies were included and organized into four main domains: precision medicine and phenotypic subclassification; classical biomarkers, such as HOMA-IR, QUICKI, Matsuda index, and TyG index; emerging biomarkers, including branched-chain amino acids, α-hydroxybutyrate, metabolomic signatures, and microRNAs; and personalized therapies, such as intensive weight-loss interventions, metabolic surgery, GLP-1 receptor agonists, dual GIP/GLP-1 receptor agonists, and SGLT2 inhibitors. The findings showed that a subgroup-based approach is methodologically more appropriate given the heterogeneity of studies, populations, biomarkers, and interventions. Classical biomarkers remain useful for screening and initial stratification, whereas omics-based markers show potential for prognostic refinement and early identification of metabolic risk. Therapeutic interventions showed greater relevance when targeted to the patient’s clinical and metabolic profile. In conclusion, precision endocrinology applied to insulin resistance represents a promising frontier for early diagnosis, therapeutic personalization, prevention of type 2 diabetes, and reduction of cardiometabolic complications. Keywords: insulin resistance; precision endocrinology; biomarkers; personalized therapies.
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (01)
EVOLUÇÃO DA ECOCARDIOGRAFIA INTRACARDÍACA 3D NAS TÉCNICAS TRANSCATETER DE REPARO E SUBSTITUIÇÃO DA VALVA TRICÚSPIDE (T-TEER E TTVR): REVISÃO SISTEMÁTICA E METANÁLISE DE RESULTADOS CLÍNICOS E PROCEDIMENTAIS
Background: Significant tricuspid regurgitation is associated with increased morbidity and mortality. In recent years, the development of transcatheter interventions, including transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR), has expanded therapeutic options for high surgical risk patients. Intraprocedural imaging quality is critical for procedural success, with three-dimensional echocardiography—particularly three-dimensional intracardiac echocardiography (3D ICE) and three-dimensional transesophageal echocardiography (3D TEE)—playing an increasingly important role. Objective: To evaluate, through a systematic review, the role of three-dimensional echocardiography in guiding T-TEER and TTVR, focusing on clinical and procedural outcomes. Methods: A systematic review was conducted according to PRISMA 2020 guidelines. Searches were performed in PubMed/MEDLINE, Scopus, and Embase between 2015 and 2025. Original studies involving T-TEER or TTVR guided by 3D ICE or 3D TEE and reporting clinical or procedural outcomes were included. A partial quantitative synthesis and structured narrative analysis were performed due to methodological heterogeneity. Results: Ten studies were included. High procedural success rates were consistently reported in studies using three-dimensional imaging, with significant reduction in tricuspid regurgitation following T-TEER. Three-dimensional TEE was the predominant modality in multicenter studies, while 3D ICE demonstrated technical feasibility as an alternative or complementary intraprocedural imaging strategy. Early mortality was low, and evidence of annular remodeling following intervention was reported. Conclusion: Three-dimensional echocardiography plays a fundamental role in the evolution of transcatheter tricuspid interventions. 3D ICE emerges as a promising technology with potential procedural advantages; however, prospective comparative trials are needed to define its incremental clinical impact. Keywords: Tricuspid regurgitation; Three-dimensional echocardiography; Transcatheter edge-to-edge repair; Intracardiac echocardiography.
- 1 January 2026
- Published by IPEDSS - Instituto de Pesquisa e Determinacao Social da Saude Ltda in Revista Científica Ipedss
- Vol. 06 (01)
EVOLUÇÃO DA ECOCARDIOGRAFIA INTRACARDÍACA 3D NAS TÉCNICAS TRANSCATETER DE REPARO E SUBSTITUIÇÃO DA VALVA TRICÚSPIDE (T-TEER E TTVR): REVISÃO SISTEMÁTICA E METANÁLISE DE RESULTADOS CLÍNICOS E PROCEDIMENTAIS
Background: Significant tricuspid regurgitation is associated with increased morbidity and mortality. In recent years, the development of transcatheter interventions, including transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR), has expanded therapeutic options for high surgical risk patients. Intraprocedural imaging quality is critical for procedural success, with three-dimensional echocardiography—particularly three-dimensional intracardiac echocardiography (3D ICE) and three-dimensional transesophageal echocardiography (3D TEE)—playing an increasingly important role. Objective: To evaluate, through a systematic review, the role of three-dimensional echocardiography in guiding T-TEER and TTVR, focusing on clinical and procedural outcomes. Methods: A systematic review was conducted according to PRISMA 2020 guidelines. Searches were performed in PubMed/MEDLINE, Scopus, and Embase between 2015 and 2025. Original studies involving T-TEER or TTVR guided by 3D ICE or 3D TEE and reporting clinical or procedural outcomes were included. A partial quantitative synthesis and structured narrative analysis were performed due to methodological heterogeneity. Results: Ten studies were included. High procedural success rates were consistently reported in studies using three-dimensional imaging, with significant reduction in tricuspid regurgitation following T-TEER. Three-dimensional TEE was the predominant modality in multicenter studies, while 3D ICE demonstrated technical feasibility as an alternative or complementary intraprocedural imaging strategy. Early mortality was low, and evidence of annular remodeling following intervention was reported. Conclusion: Three-dimensional echocardiography plays a fundamental role in the evolution of transcatheter tricuspid interventions. 3D ICE emerges as a promising technology with potential procedural advantages; however, prospective comparative trials are needed to define its incremental clinical impact. Keywords: Tricuspid regurgitation; Three-dimensional echocardiography; Transcatheter edge-to-edge repair; Intracardiac echocardiography.
- Open Access
- 1 July 2025
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 7 (7) , 1510-1522
VOLUMINOUS BAKER'S CYST IN THE RIGHT KNEE
Context: Baker's cyst, also known as popliteal cyst, is one of the most common cystic affections in the posterior region of the knee. Its formation occurs due to the accumulation of synovial fluid in the gastrocnemius-semimembranosus bursa, frequently associated with intra-articular pathologies that elevate pressure within the knee. Although often asymptomatic, it can manifest with pain, swelling, and limited movement. Objective: This article aims to report a case of a voluminous Baker's cyst in the right knee, highlighting its clinical and diagnostic characteristics and the response to conservative treatment. Case Report: A 54-year-old female patient presented with complaints of intense pain and a palpable mass in the right popliteal fossa. Diagnostic investigation via ultrasound revealed a large Baker's cyst, measuring 7.9 x 1.6 x 5.2 cm, with internal debris. A notable finding was the absence of detectable underlying intra-articular pathologies by ultrasonography, with no apparent osteoarthritis. Treatment was based on non-steroidal anti-inflammatory drugs and physical therapy, resulting in significant clinical improvement for the patient within just two weeks. Conclusion: Baker's cyst can be symptomatic due to its size or a one-way valve mechanism, even in the absence of evident joint lesions, reinforcing the need for an in-depth understanding of these factors for effective clinical diagnosis and management.
- 1 July 2025
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 7 (7) , 1510-1522
Open AccessVOLUMINOUS BAKER'S CYST IN THE RIGHT KNEE
Context: Baker's cyst, also known as popliteal cyst, is one of the most common cystic affections in the posterior region of the knee. Its formation occurs due to the accumulation of synovial fluid in the gastrocnemius-semimembranosus bursa, frequently associated with intra-articular pathologies that elevate pressure within the knee. Although often asymptomatic, it can manifest with pain, swelling, and limited movement. Objective: This article aims to report a case of a voluminous Baker's cyst in the right knee, highlighting its clinical and diagnostic characteristics and the response to conservative treatment. Case Report: A 54-year-old female patient presented with complaints of intense pain and a palpable mass in the right popliteal fossa. Diagnostic investigation via ultrasound revealed a large Baker's cyst, measuring 7.9 x 1.6 x 5.2 cm, with internal debris. A notable finding was the absence of detectable underlying intra-articular pathologies by ultrasonography, with no apparent osteoarthritis. Treatment was based on non-steroidal anti-inflammatory drugs and physical therapy, resulting in significant clinical improvement for the patient within just two weeks. Conclusion: Baker's cyst can be symptomatic due to its size or a one-way valve mechanism, even in the absence of evident joint lesions, reinforcing the need for an in-depth understanding of these factors for effective clinical diagnosis and management.